We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Electrophysiological investigation of adenosine trisphosphate-sensitive potassium channels in the rat substantia nigra pars reticulata.
Neuroscience 1996 September
Adenosine trisphosphate-sensitive potassium (K-ATP) channels in the substantia nigra pars reticulata were studied in rat brain slices using whole-cell patch clamp recording. Substantia nigra pars reticula neurons were identified as such by their spontaneous action potential firing at mean rate of 15.3 Hz1 virtual absence of hyperpolarization-activated inward current Ih1 and unresponsiveness to dopamine (30 microM), quinirole (10 microM) and (Met)enkephalin (10 microM). Intracellular dialysis with Mg(2+0-ATP-free pipette solutions caused a slowly developing membrane hyperpolarization (13 +/- 4 mV), accompanied by a cessation of action potential firing, or an outward current (79 +/- 30 pA at around -60 mV), which were reversed b the sulphonylurea K-ATO channel blockers tolbutamide (100 microM) and glibenclamide (3 microM). When Mg(2+0-ATP (2 mM) was included in the recording pipette no membrane hyperpolarization or outward current was observed. Neither the sulphonylureas nor the potassium channel activator lemakalim (200 MicroM) altered membrane potential, firing rate or holding current under these recording conditions. The outward current induced by dialysis with Mg(2+)-ATP-free solutions reversed polarity negative to -94 +/- 9 mV (9 cells), close to the estimated K+ equilibrium potential (-105 mV) for the conditions used, and was associated with a conductance increase that was blocked by Ba2+ (100 microM). The current blocked by the sulphonylureas had a similar reversal potential (-97 +/- 7 MV; 13 cells), and both currents were voltage independent over the range -50 to -100 mV with slope conductance of approximately 2.0 nS. Outward synaptic current were evoked by single shock electrical simulation, in the presence of glutamate receptor antagonists, at a holding potential of -50 mV. These synaptic currents were blocked by bicuculline (10 microM) and reversed polarity at around -65 mV, close to the Cl- equilibrium potential, and were thus mediated by GABAA receptors. They were reversibly depressed by 37 +/- 14% in lemakalim (200 microM) in 6/12 cells tested, an effect that was partially reversed by tolbutamide (200 microM). It is concluded that functional K-ATP channels are present both presynaptically and postsynaptically in the substantia nigra pars reticulata. Postsynaptic K-ATP channels may control excitability in conditions where intracellular ATP is reduced, whereas presynaptic K-ATP channels, sensitive to the potassium channel activator lemakalim, can modulate the release of GABA, which probably arises from fibres of extranigral origin. Pharmacological differences between these two sites could be exploited to treat epilepsies, dyskinesias and akinesia.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app